keyword
https://read.qxmd.com/read/38526250/a-study-on-geographic-correlation-between-indoor-radon-exposure-and-leukemia-incidence-in-canada
#21
JOURNAL ARTICLE
Jing Chen
In Canada, leukemia is diagnosed at a rate of 15 cases per 100,000 persons and accounts for about 3% of all new primary cancers. In this study, geographical correlation between residential radon exposure and leukemia incidence was investigated at a provincial level with more accurate long-term radon measurement data in 21,330 homes and 10-y (2000-2009) age standardized incidence rates per 100,000 population for various subtypes of leukemia. The analyses showed that the incidence rate of non-Hodgkin lymphoma is statistically significantly correlated with average indoor radon (222Rn) concentration for Canadian females (p = 0...
May 1, 2024: Health Physics
https://read.qxmd.com/read/38517235/phase-ii-study-of-the-novel-antifolate-agent-pralatrexate-in-combination-with-the-histone-deacetylase-inhibitor-romidepsin-for-the-treatment-of-patients-with-mature-t-cell-lymphoma
#22
JOURNAL ARTICLE
Yun Kyoung Ryu Tiger, Salvia Jain, Stefan K Barta, Seda Tolu, Brian Estrella, Ahmed Sawas, Jennifer K Lue, Mark M Francescone, Barbara Pro, Jennifer E Amengual
Previously, we conducted a Phase I study of the combination of pralatrexate and romidepsin in patients with relapsed/refractory (R/R) lymphomas and subsequently conducted a multicenter Phase II study in patients with untreated or R/R mature T cell lymphomas (MTCL). Patients received pralatrexate 25 mg/m2 and romidepsin 12 mg/m2 every 2 weeks. Fourteen patients were evaluable for efficacy. Overall response rate was 35.7% with CR in 14.3% and disease control in 50%. The mDOR was 8.2 months, mPFS was 3...
March 22, 2024: Leukemia & Lymphoma
https://read.qxmd.com/read/38495131/effect-of-rituximab-on-immune-status-in-children-with-aggressive-mature-b-cell-lymphoma-leukemia-a-prospective-study-from-cccg-bnhl-2015
#23
JOURNAL ARTICLE
Jiajia Dong, Zhou Xu, Xia Guo, Fanghua Ye, Chenying Fan, Ju Gao, Yijin Gao, Liangchun Yang
BACKGROUND: Limited research has been conducted on the impact of rituximab on immune function and the incidence of side effects in children undergoing combination chemotherapy for aggressive mature B-cell lymphoma/leukemia. METHODS: Clinical data from 85 patients with primary pediatric aggressive mature B-cell lymphoma/leukemia, treated according to the Chinese Children's Cancer Group (CCCG)-mature B-cell non-Hodgkin lymphoma (BNHL)-2015 protocol from June 1, 2015, to December 1, 2022, were collected from three tertiary medical centers in China...
March 15, 2024: Heliyon
https://read.qxmd.com/read/38486446/flow-cytometry-is-a-sensitive-technique-to-assess-marrow-involvement-by-b-cell-non-hodgkins-lymphoma
#24
JOURNAL ARTICLE
Thulasi Raman Ramalingam
No abstract text is available yet for this article.
March 14, 2024: Leukemia & Lymphoma
https://read.qxmd.com/read/38472612/optimization-of-mhealth-behavioral-interventions-for-patients-with-chronic-lymphocytic-leukemia-the-health4cll-study
#25
JOURNAL ARTICLE
Che Young Lee, Max J Gordon, Melissa M Markofski, Emily C LaVoy, Susan K Peterson, Liang Li, Sara Fares, Miranda Baum, Margaret Pace, Danielle Walsh, Alessandra Ferrajoli, Karen Basen-Engquist
PURPOSE: This pilot study of a diet and physical activity intervention (HEALTH4CLL) was conducted to reduce fatigue and improve physical function (PF) in patients with chronic lymphocytic leukemia (CLL). METHODS: The HEALTH4CLL study used a randomized factorial design based on the multiphase optimization strategy (MOST). Patients received diet, exercise, and body weight management instructional materials plus a Fitbit and were randomized to undergo one of 16 combinations of 4 evidence-based mHealth intervention strategies over 16 weeks...
March 13, 2024: Journal of Cancer Survivorship: Research and Practice
https://read.qxmd.com/read/38468840/flt3-mutated-acute-myeloid-leukemia-after-cd19-car-t-cells
#26
JOURNAL ARTICLE
Eugenio Galli, Filippo Frioni, Tanja Malara, Enrico Attardi, Silvia Bellesi, Stefan Hohaus, Simona Sica, Federica Sorà, Patrizia Chiusolo
No abstract text is available yet for this article.
2024: Mediterranean Journal of Hematology and Infectious Diseases
https://read.qxmd.com/read/38459171/hematopoietic-cell-transplantation-and-cell-therapy-activity-landscape-survey-in-the-kingdom-of-saudi-arabia-a-report-from-the-saudi-society-of-blood-and-marrow-transplantation-ssbmt
#27
JOURNAL ARTICLE
(no author information available yet)
Hematopoietic Cell Transplantation (HCT) activity was surveyed in the Kingdom of Saudi Arabia (KSA). The overall rate of HCT per 10,000,000 inhabitants doubled every 10 years. 15,031 HCTs were reported by all the functional HCT centers in KSA since inception of HCT program. Out of total HCT 15,031; 10,232(68%) were reported in adults, and 4799(32%) in the pediatric population. Allogeneic HCT constituted 10,489(70%) of total HCT, with majority from Human Leukocyte Antigen matched identical sibling (85.4%)...
March 8, 2024: Bone Marrow Transplantation
https://read.qxmd.com/read/38456694/lenalidomide-rituximab-r-2-and-ixazomib-for-frontline-treatment-of-high-risk-follicular-and-indolent-non-hodgkin-lymphoma
#28
JOURNAL ARTICLE
Brian T Hill, Yanwen Chen, Deepa Jagadeesh, Robert Dean, Omer Koc, Kirsten Boughan, Brenda Cooper, Brad Pohlman, Paolo Caimi, Mitchell R Smith
Lenalidomide and rituximab (R2 ) is an effective frontline treatment for patients with indolent B-cell non-Hodgkin lymphoma (iNHL). We investigated the safety and efficacy of addition of the proteasome inhibitor ixazomib to R 2 for treatment of iNHL through a phase I/II clinical trial for high-risk patients. Twenty patients were enrolled, 18 were treated. The target dose of ixazomib 4 mg weekly was achieved during dose escalation. The most common treatment-related adverse events (AEs) were low grade gastrointestinal, rash, neuropathy, and myalgia/arthralgia...
March 8, 2024: Leukemia & Lymphoma
https://read.qxmd.com/read/38456027/presumptive-pulmonary-toxocariasis-in-a-patient-affected-by-acute-myeloid-leukemia-and-hodgkin-lymphoma-case-report-and-review-of-the-literature-in-immunocompromised-hosts
#29
Tommaso Lupia, Elena Crisà, Valentina Sangiorgio, Roberta Bosio, Giacomo Stroffolini, Elena Staffilano, Vanesa Gregorc, Silvia Corcione, Francesco Giuseppe De Rosa
Toxocariasis is a zoonosis transmitted by the nematode Toxocara spp. Immunocompromised hosts are more susceptible than general population to bacterial, viral, fungal and parasitic infections. In this population toxocariasis may present as exacerbation or reactivation and could have severe or atypical manifestations being a diagnostic challenge for healthcare providers. We report a case of a presumptive pulmonary toxocariasis during chemotherapy in a patient affected by acute myeloid leukaemia (AML) and Hodgkin lymphoma and we summarize current evidence of pulmonary involvement in immunocompromised population with Toxocara spp infection in a narrative review...
2024: Le Infezioni in Medicina
https://read.qxmd.com/read/38451372/update-on-t-cell-lymphoma-epidemiology
#30
REVIEW
Jane J Chen, Franco Castillo Tokumori, Christina Del Guzzo, Jeanyoung Kim, Jia Ruan
PURPOSE OF REVIEW: T-cell lymphomas (TCLs) are a group of rare subtypes of non-Hodgkin lymphoma derived from mature T-lymphocytes. Recent updates in lymphoma classification based on the cell-of-origin pathogenesis have shed new light on TCL epidemiology and outcomes. Contemporary regional consortia and international studies, including those conducted recently in Asia and South America, have provided an updated delineation of the major subtypes across various global regions. RECENT FINDINGS: Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), remains the most common subtype globally except in Asia, where extra-nodal NK-T cell lymphoma (ENKTL) has emerged as the most prevalent...
March 7, 2024: Current Hematologic Malignancy Reports
https://read.qxmd.com/read/38451181/genetically-determined-telomere-length-as-a-risk-factor-for-hematological-malignancies-evidence-from-mendelian-randomization-analysis
#31
JOURNAL ARTICLE
Tian Fang, Zhihao Zhang, Kexing Ren, Liqun Zou
BACKGROUND: Over the past years, the exact correlation between telomere length and hematological malignancies was still not fully understood. METHODS: We performed a two-sample Mendelian randomization study to investigate the causal relationship between telomere length and hematological malignancies. We selected genetic instruments associated with telomere length. The genetic associations for lymphoid and hematopoietic malignant neoplasms were obtained from the most recent publicly accessible FinnGen study R9 data...
March 6, 2024: Aging
https://read.qxmd.com/read/38447191/a-case-of-a-patient-with-therapy-related-core-binding-factor-cbf-acute-myeloid-leukemia-cbf-aml
#32
JOURNAL ARTICLE
Elizabeth Lee, Artemio Zavala, Anirudh Murthy, Luke Li, Tahmeena Ahmed, Paula Fernicola, Christina Giordano, Cynthia Poerio, Ann-Leslie Zaslav, Gabriela Evans, Carlos A Tirado
Identifying therapy-related AML (t-AML) of newly diagnosed acute leukemias is of great interest. Development of t-AML can occur after cytotoxic chemotherapy and/or radiation. We report a case of t-AML with CBFB::MYH11 fusion in a patient with a distant history of treated stage IIIB nodular sclerosing Hodgkin's lymphoma. We present the clinical course of the patient and the methods used to detect and monitor the rearrangement. Core binding factor AML (CBF-AML) after exposure to treatment is considered to be a good prognostic marker...
2024: Journal of the Association of Genetic Technologists
https://read.qxmd.com/read/38444670/not-only-a-therapeutic-target-mtor-in-hodgkin-lymphoma-and-acute-lymphoblastic-leukemia
#33
Miguel Enrique Cuéllar Mendoza, Francisco Raúl Chávez Sánchez, Elisa María Dorantes Acosta, Ana María Niembro Zúñiga, Rosana Pelayo, Marta Zapata Tarrés
INTRODUCTION: The mechanistic/mammalian target of rapamycin (mTOR) is a serine/threonine kinase, which is downregulated or upregulated and is implicated in different types of cancer including hematologic neoplasms, skin prostate, and head and neck cancer. AIM: The aim of this study was to explore the current knowledge of mTOR signaling in acute lymphoblastic leukemia and Hodgkin lymphoma. METHODS: A systematic review was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, searching PubMed, Discovery Service for National Autonomous University of Mexico, Registro Nacional de Instituciones y Empresas Científicas y Tecnológicas (RENIECYT), and Scientific Electronic Library Online (SciELO) from 1994 to 2023...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38437681/chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma-arising-in-the-pituitary-gland-illustrative-case
#34
JOURNAL ARTICLE
Hang Zhou, Xiaowei Zhang, Xin Jia, Liang Jia, Qingjiu Zhang
BACKGROUND: The authors describe a 60-year-old female who underwent a correlative examination for an accidental scalp injury, revealing a sellar mass, which was surgically excised and pathologically confirmed to be a non-Hodgkin's small B-cell lymphoma. These findings in combination with the immunophenotype led to a final diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma. Previous studies have shown that hematological solid tumors occurring in the pituitary gland are extremely rare, and there are only approximately three other cases of living patients with similarities to this case, all of which had ambiguous expression of subsequent hematological treatment...
March 4, 2024: J Neurosurg Case Lessons
https://read.qxmd.com/read/38434151/a%C3%A2-%C3%A2-avd-for-treatment-of-hodgkin-lymphoma-variant-of-richter-s-transformation
#35
Benjamin Heyman, Michael Choi, Thomas J Kipps
Hodgkin lymphoma variant of Richter's transformation (HvRT) is a rare complication for patients with chronic lymphocytic leukemia (CLL), with an overall poor prognosis. We present the first known case series of patients with HvRT treated with the combination of brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine (A + AVD). In our series of 4 patients, two patients treated with A + AVD for HvRT had durable remissions of 40 and 42 months, while two patients had disease progression and ultimately died...
2024: Case Reports in Hematology
https://read.qxmd.com/read/38419458/collection-efficiency-and-safety-of-large-volume-leukapheresis-for-the-manufacturing-of-tisagenlecleucel
#36
JOURNAL ARTICLE
Wataru Kitamura, Tomohiro Urata, Keiko Fujii, Takuya Fukumi, Kazuhiro Ikeuchi, Keisuke Seike, Hideaki Fujiwara, Noboru Asada, Daisuke Ennishi, Ken-Ichi Matsuoka, Fumio Otsuka, Yoshinobu Maeda, Nobuharu Fujii
BACKGROUND: In patients with relapsed or refractory B cell acute lymphoblastic leukemia or B cell non-Hodgkin lymphoma (r/r B-ALL/B-NHL) with low CD3+ cells in the peripheral blood (PB), sufficient CD3+ cell yield in a single day may not be obtained with normal-volume leukapheresis (NVL). Large-volume leukapheresis (LVL) refers to the processing of more than three times the total blood volume (TBV) in a single session for PB apheresis; however, the efficiency and safety of LVL for manufacturing of tisagenlecleucel (tisa-cel) remain unclear...
February 28, 2024: Transfusion
https://read.qxmd.com/read/38416167/ommaya-reservoir-use-in-pediatric-all-and-nhl-a-review-at-st-jude-children-s-research-hospital
#37
JOURNAL ARTICLE
Alyssa Gaietto, John C Panetta, Jennifer L Pauley, Mary V Relling, Raul Ribeiro, Matthew J Ehrhardt, Ching-Hon Pui, Hiroto Inaba, Hope D Swanson
PURPOSE: The intraventricular route of chemotherapy administration, via an Ommaya Reservoir (OmR) improves drug distribution in the central nervous system (CNS) compared to the more commonly used intrathecal administration. We retrospectively reviewed our experience with intraventricular chemotherapy, focused on methotrexate, in patients with Acute Lymphoblastic Leukemia (ALL) and Non-Hodgkin Lymphoma (NHL). METHODS: Twenty-four patients (aged 7 days - 22.2 years) with 26 OmR placements were identified for a total of 25,009 OmR days between 1990 and 2019...
February 28, 2024: Cancer Chemotherapy and Pharmacology
https://read.qxmd.com/read/38393686/genetically-predicted-telomere-length-and-the-risk-of-11-hematological-diseases-a-mendelian-randomization-study
#38
JOURNAL ARTICLE
Yimin Wang, Qi Liu, Shibing Liang, Minghao Yao, Huimin Zheng, Dongqing Hu, Yifei Wang
OBJECTIVE: Previous studies have demonstrated that various hematologic diseases (HDs) induce alterations in telomere length (TL). The aim of this study is to investigate whether genetically predicted changes in TL have an impact on the risk of developing HDs. METHODS: GWAS data for TL and 11 HDs were extracted from the database. The R software package "TwoSampleMR" was employed to conduct a two-sample Mendelian randomization (MR) analysis, in order to estimate the influence of TL changes on the risk of developing the 11 HDs...
February 22, 2024: Aging
https://read.qxmd.com/read/38382169/adipose-tissue-indices-predict-prognosis-in-hodgkin-lymphoma
#39
JOURNAL ARTICLE
Demircan Özbalcı, Mehmet Erdoğan, Emine Güçhan Alanoğlu, Sevim Süreyya Şengül, Kamuran Yüceer, Hande Nur Eroğlu, Samet Yağcı
INTRODUCTION BACKGROUND: This study evaluated the impact of adipose tissue indices on prognosis of HL. METHODS: Fifty-five patients with newly diagnosed Hodgkin Lymphoma were evaluated retrospectively for association with adipose tissue indices (total abdominal tissue volume, radiodensity, subcutaneous and visceral adipose tissue SUVmax value and prognostic factors for Hodgkin Lymphoma such as IPS-3, IPS-7, stage, sedimentation, progression free and overall survival...
February 15, 2024: Leukemia Research
https://read.qxmd.com/read/38366656/pm2-5-vegetation-density-and-childhood-cancer-a-case-control-registry-based-study-from-texas-1995-2011
#40
JOURNAL ARTICLE
Lindsay A Williams, David Haynes, Jeannette M Sample, Zhanni Lu, Ali Hossaini, Laura A McGuinn, Thanh T Hoang, Philip J Lupo, Michael E Scheurer
BACKGROUND: Air pollution is positively associated with some childhood cancers while greenness is inversely associated with some adult cancers. The interplay between air pollution and greenness in childhood cancer etiology is unclear. We estimated the association between early life air pollution and greenness exposure and childhood cancer in Texas (1995-2011). METHODS: We included 6,101 cancer cases and 109,762 controls (aged 0-16 years). We linked residential birth address to census tract annual average particulate matter ≤2...
February 15, 2024: Journal of the National Cancer Institute
keyword
keyword
8449
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.